{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:44:15Z","timestamp":1790397855340,"version":"4.1.0"},"reference-count":30,"publisher":"The Endocrine Society","issue":"9","funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Sleep-related breathing disorders (SRBD) are common in people with Prader-Willi syndrome (PWS). Young adults with PWS benefit from GH continuation after attaining adult height by maintaining the improved body composition obtained during childhood. There are, no studies about the effects of GH on SRBD in young adults with PWS who were treated with GH during childhood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Investigate the effects of GH vs placebo on SRBD in young adults with PWS who were treated with GH during childhood and had attained adult height.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Two-year, randomized, double-blind, placebo-controlled, crossover study in 27 young adults with PWS, stratified for sex and body mass index.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Dutch PWS Reference Center.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>Crossover intervention with GH (0.67 mg\/m2\/d) and placebo, both over one year.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Apnea hypopnea index (AHI), obstructive apnea index (OAI), central apnea index (CAI), measured by polysomnography.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with placebo, GH did not increase AHI, CAI, or OAI (P &amp;gt; 0.35). The effect of GH vs placebo was neither different between men and women, nor between patients with a deletion or maternal uniparental disomy\/imprinting center defect. After two years, there was no difference in AHI, CAI, or OAI compared with baseline (P &amp;gt; 0.18). Two patients (7%) fulfilled the criteria of obstructive sleep apnea regardless of GH or placebo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>GH compared with placebo does not cause a substantial increase in AHI, CAI, or OAI in adults with PWS who were treated with GH during childhood and have attained adult height. Our findings are reassuring and prove that GH can be administered safely.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2019-00391","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T13:02:59Z","timestamp":1555592579000},"page":"3931-3938","source":"Crossref","is-referenced-by-count":16,"title":["Sleep-Related Breathing Disorders in Young Adults With Prader-Willi Syndrome: A Placebo-Controlled, Crossover GH Trial"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-4284","authenticated-orcid":false,"given":"Stephany H","family":"Donze","sequence":"first","affiliation":[{"name":"Dutch Growth Research Foundation, AH Rotterdam, Netherlands"},{"name":"Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center\/Sophia Children\u2019s Hospital, GD Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al W","family":"de Weerd","sequence":"additional","affiliation":[{"name":"Sleep-Wake Center SEIN, BV Zwolle, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renilde A S","family":"van den Bossche","sequence":"additional","affiliation":[{"name":"Sleep-Wake Center SEIN, BV Zwolle, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen F M","family":"Joosten","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Intensive Care Unit, Erasmus University Medical Center\/Sophia Children\u2019s Hospital, GD Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C S","family":"Hokken-Koelega","sequence":"additional","affiliation":[{"name":"Dutch Growth Research Foundation, AH Rotterdam, Netherlands"},{"name":"Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center\/Sophia Children\u2019s Hospital, GD Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"issue":"1","key":"2020071700345850300_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med"},{"issue":"12","key":"2020071700345850300_bib2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","article-title":"Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings","volume":"38","author":"Angulo","year":"2015","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2020071700345850300_bib3","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1210\/jc.2008-0649","article-title":"Recommendations for the diagnosis and management of Prader-Willi syndrome","volume":"93","author":"Goldstone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071700345850300_bib4","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/ppul.23177","article-title":"Sleep disordered breathing in patients with Prader-Willi syndrome: a multicenter study","volume":"50","author":"Pavone","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"2020071700345850300_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5664\/jcsm.3616","article-title":"Prader Willi syndrome and obstructive sleep apnea: co-occurrence in the pediatric population","volume":"10","author":"Sedky","year":"2014","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"2020071700345850300_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/sleep\/zsx162","article-title":"Prevalence and phenotype of sleep disorders in 60 adults with Prader-Willi syndrome","volume":"40","author":"Ghergan","year":"2017","journal-title":"Sleep"},{"issue":"12","key":"2020071700345850300_bib7","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1210\/jc.2006-0765","article-title":"Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment","volume":"91","author":"Festen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071700345850300_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2869.1994.tb00115.x","article-title":"Sleep apnoea in the Prader-Willi syndrome","volume":"3","author":"Clift","year":"1994","journal-title":"J Sleep Res"},{"issue":"11","key":"2020071700345850300_bib9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s004310051246","article-title":"Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome","volume":"158","author":"Lindgren","year":"1999","journal-title":"Eur J Pediatr"},{"issue":"7","key":"2020071700345850300_bib10","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1210\/jc.2008-2808","article-title":"The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome","volume":"94","author":"de Lind van Wijngaarden","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071700345850300_bib11","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2020071700345850300_bib12","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1210\/jc.2013-2012","article-title":"Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects","volume":"98","author":"Bakker","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2020071700345850300_bib13","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1210\/jc.2018-00687","article-title":"Improved mental and motor development during 3 years of GH treatment in very young children weith Prader-Willi syndrome","volume":"103","author":"Donze","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2020071700345850300_bib14","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1210\/jc.2012-1182","article-title":"Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study","volume":"97","author":"Siemensma","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071700345850300_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1352\/1944-7558-120.4.315","article-title":"Beneficial effects of long-term growth hormone treatment on adaptive functioning in infants with Prader-Willi syndrome","volume":"120","author":"Lo","year":"2015","journal-title":"Am J Intellect Dev Disabil"},{"issue":"3","key":"2020071700345850300_bib16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2009-1389","article-title":"Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome","volume":"95","author":"Carrel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071700345850300_bib17","first-page":"52","article-title":"Respiratory Complications in Children with Prader Willi Syndrome","volume":"22","author":"Tan","year":"2017","journal-title":"Paediatr Respir Rev"},{"issue":"11","key":"2020071700345850300_bib18","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1210\/jc.2016-2594","article-title":"Beneficial effects of GH in young adults with Prader-Willi syndrome: a 2-year crossover trial","volume":"101","author":"Kuppens","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071700345850300_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/ajcn\/66.2.232","article-title":"Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents","volume":"66","author":"Boot","year":"1997","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2020071700345850300_bib20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1203\/00006450-200003000-00006","article-title":"Continuing positive secular growth change in The Netherlands 1955-1997","volume":"47","author":"Fredriks","year":"2000","journal-title":"Pediatr Res"},{"issue":"2","key":"2020071700345850300_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/adc.82.2.107","article-title":"Body index measurements in 1996-7 compared with 1980","volume":"82","author":"Fredriks","year":"2000","journal-title":"Arch Dis Child"},{"key":"2020071700345850300_bib22","volume-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications","author":"Iber","year":"2007"},{"key":"2020071700345850300_bib23","article-title":"International Classification of Sleep Disorders","author":"American Academy of Sleep Medicine","year":"2014","edition":"3rd ed"},{"issue":"3","key":"2020071700345850300_bib24","first-page":"166","article-title":"Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency","volume":"50","author":"Rikken","year":"1998","journal-title":"Horm Res"},{"issue":"2","key":"2020071700345850300_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cen.13247","article-title":"Metabolic health profile in young adults with Prader-Willi syndrome: results of a 2-year randomized, placebo-controlled, crossover GH trial","volume":"86","author":"Kuppens","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071700345850300_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1210\/jc.2005-1279","article-title":"Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome","volume":"91","author":"Miller","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071700345850300_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpeds.2012.07.042","article-title":"Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi syndrome during 2 years of growth hormone therapy","volume":"162","author":"Al-Saleh","year":"2013","journal-title":"J Pediatr"},{"issue":"7","key":"2020071700345850300_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/archdischild-2016-311298","article-title":"Longitudinal evaluation of sleep disordered breathing in infants with Prader-Willi syndrome","volume":"102","author":"Khayat","year":"2017","journal-title":"Arch Dis Child"},{"issue":"9","key":"2020071700345850300_bib29","doi-asserted-by":"crossref","first-page":"E1516","DOI":"10.1210\/jc.2013-1831","article-title":"Growth hormone therapy and respiratory disorders: long-term follow-up in PWS children","volume":"98","author":"Berini","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071700345850300_bib30","doi-asserted-by":"crossref","first-page":"e101012","DOI":"10.1371\/journal.pone.0101012","article-title":"Clinically important age-related differences in sleep related disordered breathing in infants and children with Prader-Willi Syndrome","volume":"9","author":"Cohen","year":"2014","journal-title":"PLoS One"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/jc.2019-00391\/28475068\/jc.2019-00391.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/9\/3931\/29027701\/jc.2019-00391.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/9\/3931\/29027701\/jc.2019-00391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T14:48:20Z","timestamp":1594997300000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/9\/3931\/5473526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,18]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2019-00391","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,4,18]]}}}